Capecitabine

$55$198

Products Details

Product Description

– Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase.

Web ID

– HY-B0016

Storage Temperature

– -20°C, 3 years; 4°C, 2 years (Powder)

Shipping

– Room Temperature

Applications

– Cancer-programmed cell death

Molecular Formula

– C15H22FN3O6

References

– [1]PharmD CM, et al. Capecitabine: A review. Clinical Therapeutics. 2005 Jan; 27(1): 23-44.|[2]Guichard SM, et al. Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity. Eur J Cancer. 2008 Jan;44(2):310-7.

CAS Number

– 154361-50-9

Molecular Weight

– 359.35

Compound Purity

– 99.87

SMILES

– O[C@H]1[C@@H](O)[C@H](N2C=C(C(NC(OCCCCC)=O)=NC2=O)F)O[C@@H]1C

Clinical Information

– Launched

Research Area

– Cancer

Solubility

– DMSO : 250 mg/mL (ultrasonic)|H2O : ≥ 33.33 mg/mL

Target

– Apoptosis;DNA/RNA Synthesis;Nucleoside Antimetabolite/Analog

Pathway

– Apoptosis;Cell Cycle/DNA Damage

Product type

– Reference compound

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

=

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.

=